Early Results of a Phase II Study of Ofatumumab As Front-Line Treatment in Elderly, Unfit Patients with Chronic Lymphocytic Leukemia (CLL)

被引：1
|
作者：
Ciccone, Maria [1 ]
Vitale, Candida [1 ]
Hinojosa, Christina [1 ]
Keating, Michael J. [1 ]
Pemmaraju, Naveen [1 ]
O'Brien, Susan [1 ]
Burger, Jan A. [1 ]
Thomas, Deborah A. [1 ]
Kantarjian, Hagop M. [1 ]
Strati, Paolo [1 ]
Wierda, William G. [1 ]
Ferrajoli, Alessandra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.5656.5656
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] VENETOCLAX AND RITUXIMAB (VENR) FOR THE FRONT-LINE TREATMENT OF YOUNG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND AN UNFAVORABLE BIOLOGIC PROFILE. PRELIMINARY RESULTS OF THE GIMEMA VERITAS STUDY
    Mauro, F. R.
    Reda, G.
    Arena, V.
    Visentin, A.
    Coscia, M.
    Sportoletti, P.
    Laurenti, L.
    Gaidano, G.
    Marasca, R.
    Orsucci, L.
    Murru, R.
    Stelitano, C.
    Ilariucci, F.
    Mannina, D.
    Massaia, M.
    Rigolin, G. M.
    Scarfo, L.
    Marchetti, M.
    Levato, L.
    Tani, M.
    Arcari, A.
    Musuraca, G.
    Deodato, M.
    Galieni, P.
    Patrizi, V. Belsito
    Gottardi, D.
    Liberati, A. M.
    Pietrasanta, D.
    Molica, S.
    Cassin, R.
    Vitale, C.
    Ielo, C.
    De Propris, M. S.
    Della Starza, I.
    Raponi, S.
    Nanni, M.
    Del Giudice, I.
    Paoloni, F.
    Fazi, P.
    Albano, F.
    Neri, A.
    Piciocchi, A.
    Trentin, L.
    Cuneo, A.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA, 2021, 106 (10) : 62 - 62
  • [22] Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy
    Kim, Myung Sun
    Prasad, Vinay
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 560 - 561
  • [23] Controversies in the front-line management of chronic lymphocytic leukemia
    Nabhan, Chadi
    Shanafelt, Tait D.
    Kay, Neil E.
    LEUKEMIA RESEARCH, 2008, 32 (05) : 679 - 688
  • [24] Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies
    Vitale, Candida
    Falchi, Lorenzo
    Ciccone, Maria
    Burger, Jan
    Pemmaraju, Naveen
    Borthakur, Gautam
    Wierda, William G.
    Keating, Michael J.
    Ferrajoli, Alessandra
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (01) : 19 - 23
  • [25] Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis
    Laurenti, Luca
    Vannata, Barbara
    Innocenti, Idanna
    Autore, Francesco
    Santini, Francesco
    Sora, Federica
    Za, Tommaso
    Marietti, Sara
    Bellesi, Silvia
    Sica, Simona
    Efremov, Dimitar G.
    Leone, Giuseppe
    BLOOD, 2012, 120 (21)
  • [26] Thalidomide (T) and fludarabine (F) as front-line therapy for patients (pts) with previously untreated chronic lymphocytic leukemia (CLL): Results of a phase I trial.
    Chanan-Khan, AA
    Fallon, A
    Miller, K
    Bernstein, ZP
    Hernandez, F
    Alam, A
    McCarthy, P
    Mohr, A
    Czuczman, MS
    BLOOD, 2003, 102 (11) : 675A - 675A
  • [27] Fludarabine, cyclophosphamide and rituximab (FCR) in front line treatment of patients with chronic lymphocytic leukemia (CLL)
    Grifi, Fatiha
    Bougherira, Soraya
    Djenouni, Amel
    LEUKEMIA & LYMPHOMA, 2017, 58 : 94 - 94
  • [28] Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study
    Doubek, Michael
    Brychtova, Yvona
    Panovska, Anna
    Sebejova, Ludmila
    Stehlikova, Olga
    Chovancova, Jana
    Malcikova, Jitka
    Smardova, Jana
    Plevova, Karla
    Volfova, Pavlina
    Trbusek, Martin
    Mraz, Marek
    Bakesova, Denisa
    Trizuljak, Jakub
    Hadrabova, Marketa
    Obrtlikova, Petra
    Karban, Josef
    Smolej, Lukas
    Oltova, Alexandra
    Jelinkova, Eva
    Pospisilova, Sarka
    Mayer, Jiri
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (05) : 417 - 421
  • [29] Management of unfit elderly patients with chronic lymphocytic leukemia
    Eichhorst, Barbara
    Hallek, Michael
    Goede, Valentin
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 58 : 7 - 13
  • [30] Cost-Effectiveness Comparison between Ibrutinib, Chemotherapy, and Chemoimmunotherapy in Front-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
    Nabhan, Chadi
    Nero, Damion
    Lee, Choo Hyung
    Kish, Jonathan K.
    Mato, Anthony R.
    BLOOD, 2018, 132
12345